From Silicon to Serum: The Critical Path of Validating Computational Predictions in Modern Vaccinology

Abstract

Vaccinology has undergone a profound paradigm shift—from traditional empirical discovery to a rational, engineering-based discipline. This transformation is driven by the synergistic and iterative cycle between computational (in silico) prediction and rigorous experimental validation, now the cornerstone of modern, accelerated vaccine development. This review delineates the architecture of this integrated pipeline. We first survey the expanding computational toolbox for vaccine design, spanning immunoinformatics and reverse vaccinology for antigen discovery, AI-driven structure-based engineering of stabilized immunogens, and systems vaccinology for modeling immune dynamics. We then outline the “experimental gauntlet”: a hierarchy of biochemical, cellular, and in vivo preclinical assays that verify computational hypotheses—confirming molecular structures, binding kinetics, immunogenicity, and protective efficacy. The power of this fusion is exemplified by landmark case studies: the structure-guided triumph against Respiratory Syncytial Virus (RSV), the rapid development of COVID-19 mRNA vaccines, the iterative germline-targeting design of HIV immunogens, and the frontier of personalized neoantigen cancer vaccines. Together, these advances demonstrate that the union of predictive computation and empirical validation has moved from promise to proven paradigm. Looking ahead, emerging technologies such as generative AI and immune digital twins are poised to further accelerate this virtuous cycle, transforming vaccinology into a more precise, predictable, and rapid science capable of meeting future global health challenges.